About this author
Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev
Receive by email

TNRCoverWeb120.jpg Buy on Amazon
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

Brain Waves

« Are Foundations Overlooking Mental Health? | Main | Too Intelligent? A Book Review of Jeff Hawkins’ "On Intelligence" »

October 18, 2004

Do you laugh or cry uncontrollably? Avanir's Emoticeutical Solution

Email This Entry

Posted by Zack Lynch

At last week's BIO Emerging Company Investor Forum in San Francisco I found out that more than one million people across a wide variety of neurological disorders suffer from episodes of uncontrollable laughing and/or crying called the pseudobulbar affect (also known as emotional lability).

It is estimated that 50% of ALS patients, 10% of MS patients, 15% of Alzheimer's patients, and 11% of patients one year after having a stroke suffer from this emotional disorder.

Avanir Pharmaceuticals' CEO Gerald Yakatan shared the clinical trial progress they are making on their targeted emoticeutical, Neurodex, to treat this disorder.

Currently in phase III trials, Neurodex is an excellent example of how our increased understanding of the brain is making it possible to treat specific aspects of mental disorders that cut across different diseases. It also highlights a growing trend in treating mental illness with multiple drugs (see: polypharmacy). For example, an Alzheimer's patient in 2010 will likely be prescribed a "drug cocktail" that includes an emoticeutical like Neurodex, a cogniceutical from Saegis Pharmaceuticals and a sensoceutical to treat age-related sensory decline like hearing loss.

Comments (1) + TrackBacks (0) | Category: Emoticeuticals


1. dodo on October 22, 2004 11:31 PM writes...

Comfortably numb?
God help me if somebody medicates me so I can't feel when I get old.

Permalink to Comment


Email this entry to:

Your email address:

Message (optional):

Chinese Cover of The Neuro Revolution
The Neuro Revolution Lands In China
How Neuroscience Will Change the World - My Interview on
Neuroscience Hearing on Capitol Hill Wednesday Sept 29, 2pm
The Neuro Revolution Published in Japan as "Neuro Wars"
Neurotech 2010: Translational Researchers Highlight Innovation
The Neuro Revolution in China Progressing
Speakers for Neurotech 2010 - Boston, May 19-20